Wound Dressings For Split-Thickness Skin Graft Donor Sites in Patients Undergoing Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

69 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-11-30

Study Completion Date

2010-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is to determine what dressing would work best to heal and keep from hurting, the split-thickness skin graft donor site which will be done as part of the patient's surgical procedure. Currently there is a dressing that is transparent and it is placed on the wound after surgery and wrapped with gauze and an elastic bandage. Two days after the surgery the gauze and elastic bandages are removed and the area is left with the transparent dressing. Sometimes the dressing needs to be changed because it leaks. On the fifth day this dressing is removed and the wound is left open to air. The dressing researchers are studying is a dressing that has been used for different types of wounds, as well as this type of wound. It is applied in the same manner; however, it is left in place until it falls off independently, usually around post-operative (post-op) day 10.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Wound-healing Improvement by Resurfacing Split-Thickness Skin Donor Sites With Thin Split-thickness Grafting

NCT01974583

Skin Graft Disorder Disorder of Skin Donor Site Wound Healing Disturbance of

COMPLETED

An Investigation to Evaluate a New Donor Site Dressing in Surgical Burn Patients

NCT01670201

Donor Site Complication

COMPLETED NA

Efficacy and Safety of High Absorption Pad in Split-thickness Skin Graft Donor Site Wound

NCT04299126

Disorder of Skin Donor Site

UNKNOWN NA

Evaluation of the Use of Minced Skin Grafts for Promoting Donor Site Wound Healing After Split-Thickness Skin Grafting

NCT06488612

Traumatic Skin Loss, 2nd and 3rd Degree Burn, Post Tumour Excision - Raw Areas Undergoes Split- Thickness Skin Grafts

RECRUITING NA

Activated Carbon Interphase Effect on Surgical Incisions vs.Two Common Wound Dressings

NCT04038671

Surgical Wound, Healed

WITHDRAWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVES:

I. Which dressing type and technique is most effective in minimizing pain and inflammation and promoting epithelialization in patients who have had surgery which requires the use of an anterior thigh split-thickness skin graft?

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I: Patients receive transparent film dressing (otolaryngology service) or Xeroform petroleum gel impregnated gauze dressing (surgical oncology service) after surgery.

ARM II: Patients receive native collagen wound dressing after surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Perioperative/Postoperative Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm I (control)

Patients receive transparent film dressing (otolaryngology service) or Xeroform petroleum gel impregnated gauze dressing (surgical oncology service) after surgery.

Group Type EXPERIMENTAL

wound care management

Intervention Type PROCEDURE

Receive transparent film dressing or Xeroform petroleum gel impregnated gauze dressing

questionnaire administration

Intervention Type OTHER

Ancillary studies

Arm II (native collagen wound dressing)

Patients receive native collagen wound dressing after surgery.

Group Type EXPERIMENTAL

wound care management

Intervention Type PROCEDURE

Receive native collagen wound dressing

questionnaire administration

Intervention Type OTHER

Ancillary studies

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

wound care management

Receive transparent film dressing or Xeroform petroleum gel impregnated gauze dressing

Intervention Type PROCEDURE

wound care management

Receive native collagen wound dressing

Intervention Type PROCEDURE

questionnaire administration

Ancillary studies

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Population of otolaryngological or surgical oncology patients experiencing an autologous split-thickness skin graft as part of their surgical procedure
* Patients will have a Glasgow Coma score of 15 (or 10 with a tracheostomy)
* Patient donor sites will be limited to the anterior thigh
* Patients will be free of documented circulatory deficits, neuropathy, or mental illness which prohibits their ability to independently consent or respond to questions regarding pain
* Patients will be able to give consent independently
* Patients will be able to read and write in English

Exclusion Criteria

* Patients unable to give independent consent for any reason
* Skin graft donor sites other than the anterior thigh
* Patients with a concurrent diagnosis of diabetes, peripheral vascular disease, and/or paresthesias or paralysis of the lower extremities
* Patients who are unable to complete a self-report pain scale
* Patients who are prisoners
* Patients who are known active alcoholics
* Patients on steroids or other medications known to affect healing

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No